Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    SYN Net Margin

    As of 2025-07-12, the Net Margin of Synthetic Biologics Inc (SYN) is -54.1%.

    Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

    SYN Net Margin - Historical Value
    DateValue
    2021-12-31 -54.1%
    2020-12-31 -
    2019-12-31 -
    2018-12-31 -
    2017-12-31 -
    2016-12-31 -
    2015-12-31 -
    2014-12-31 -
    2013-12-31 -
    2012-12-31 -
    SYN Net Margin - Peers Comparison
    TickerNameValue
    ACHVAchieve Life Sciences Inc-397.8%
    ADXSAyala Pharmaceuticals Inc-369784.6%
    AGEAgeX Therapeutics Inc-34866.7%
    AIKIAikido Pharma Inc-41800%
    ALNAAllena Pharmaceuticals Inc-
    APREAprea Therapeutics Inc-862.4%
    ARDSAridis Pharmaceuticals Inc-982.6%
    ATNMActinium Pharmaceuticals Inc-60269.1%
    CWBRCohBar Inc-
    DFFNDiffusion Pharmaceuticals Inc-3514.3%
    EDSAEdesa Biotech Inc-1935.6%
    FSTXF-Star Therapeutics Inc-147.8%
    HBP.TOHelix Biopharma Corp-250.8%
    LUMOLumos Pharma Inc-1659.4%
    MACKMerrimack Pharmaceuticals Inc-81%
    MNPRMonopar Therapeutics Inc-
    NPHCNutra Pharma Corp-13398.3%
    NRBONeurobo Pharmaceuticals Inc-
    QLGNQualigen Therapeutics Inc-374.3%
    RGRXRegeneRx Biopharmaceuticals Inc-2250.5%
    SLNOSoleno Therapeutics Inc-2608.2%
    SZLS.TOStageZero Life Sciences Ltd-300.5%
    VCNXVaccinex Inc-3100.5%
    WINTWindtree Therapeutics Inc-13876.3%
    YTENYield10 Bioscience Inc-24091.7%
    Tickers added to watchlist